K D B van Leeuwen1, J Rogers2, T Winzenberg3, M van Middelkoop1. 1. Department of General Practice, Erasmus MC University Medical Center Rotterdam, The Netherlands. 2. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. 3. Faculty of Health, Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Abstract
QUESTION: What (risk) factors are associated with plantar fasciopathy (PF)? DESIGN: Systematic review with meta-analyses. PARTICIPANTS: Patients with PF. FACTORS: All factors described in prospective, case-control or cross-sectional observational studies. RESULTS: 51 included studies (1 prospective, 46 case-control and 4 cross-sectional studies) evaluated a total of 104 variables. Pooling was possible for 12 variables. Higher body mass index (BMI) (BMI>27, OR 3.7 (95% CI 2.93 to 5.62)) in patients with PF was the only significant clinical association, and its effect was the strongest in the non-athletic subgroup. In people with PF compared to controls, pooled imaging data demonstrated a significantly thicker, hypoechogenic plantar fascia with increased vascular signal and perifascial fluid collection. In addition, people with PF were more likely to have a thicker loaded and unloaded heel fat pat, and bone findings, including a subcalcaneal spur and increased Tc-99 uptake. No significant difference was found in the extension of the first metatarsophalangeal joint. CONCLUSIONS: We found a consistent clinical association between higher BMI and plantar fasciopathy. This association may differ between athletic and non-athletic subgroups. While consistent evidence supports a range of bone and soft tissue abnormalities, there is lack of evidence for the dogma of clinical and mechanical measures of foot and ankle function. Clinicians can use this information in shared decision-making. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
QUESTION: What (risk) factors are associated with plantar fasciopathy (PF)? DESIGN: Systematic review with meta-analyses. PARTICIPANTS: Patients with PF. FACTORS: All factors described in prospective, case-control or cross-sectional observational studies. RESULTS: 51 included studies (1 prospective, 46 case-control and 4 cross-sectional studies) evaluated a total of 104 variables. Pooling was possible for 12 variables. Higher body mass index (BMI) (BMI>27, OR 3.7 (95% CI 2.93 to 5.62)) in patients with PF was the only significant clinical association, and its effect was the strongest in the non-athletic subgroup. In people with PF compared to controls, pooled imaging data demonstrated a significantly thicker, hypoechogenic plantar fascia with increased vascular signal and perifascial fluid collection. In addition, people with PF were more likely to have a thicker loaded and unloaded heel fat pat, and bone findings, including a subcalcaneal spur and increased Tc-99 uptake. No significant difference was found in the extension of the first metatarsophalangeal joint. CONCLUSIONS: We found a consistent clinical association between higher BMI and plantar fasciopathy. This association may differ between athletic and non-athletic subgroups. While consistent evidence supports a range of bone and soft tissue abnormalities, there is lack of evidence for the dogma of clinical and mechanical measures of foot and ankle function. Clinicians can use this information in shared decision-making. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Nadine Rasenberg; Sita Ma Bierma-Zeinstra; Patrick J Bindels; Johan van der Lei; Marienke van Middelkoop Journal: Br J Gen Pract Date: 2019-10-31 Impact factor: 5.386
Authors: Sari J Priesand; Brian M Schmidt; Lynn Ang; James S Wrobel; Michael Munson; Wen Ye; Rodica Pop-Busui Journal: J Diabetes Complications Date: 2019-06-20 Impact factor: 2.852
Authors: Hylton B Menz; Martin J Thomas; Michelle Marshall; Trishna Rathod-Mistry; Alison Hall; Linda S Chesterton; George M Peat; Edward Roddy Journal: Rheumatology (Oxford) Date: 2019-02-01 Impact factor: 7.580
Authors: Tom P Walsh; Tiffany K Gill; Angela M Evans; Alison Yaxley; Jacob A Chisholm; Lilian Kow; John B Arnold; E Michael Shanahan Journal: J Foot Ankle Res Date: 2018-06-28 Impact factor: 2.303
Authors: N Rasenberg; L Fuit; E Poppe; A J A Kruijsen-Terpstra; K J Gorter; M S Rathleff; P L J van Veldhoven; P J Bindels; S M Bierma-Zeinstra; M van Middelkoop Journal: BMC Musculoskelet Disord Date: 2016-01-16 Impact factor: 2.362